Larvol Delta - Phase-1-doseescalation-study-evaluating-the-safety-pharmacokinetics-and-clinical-activity-of-OBI3424-in-patients-with-advanced-or-metastatic-solid-tumors

OBI-3424 - OBI Pharma

http://www.ncbi.nlm.nih.gov/pubmed/37173365

May 13, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next